FOXO TECHNOLOGIES INC. Notes and Loans Payable
FOXO TECHNOLOGIES INC. (FOXO) had Notes and Loans Payable of $17.21 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Notes and Loans Payable
us-gaap:NotesAndLoansPayable · last filed 2026-08-14
- 2026-06-30: Notes and Loans Payable $17.21M.
- 2026-03-31: Notes and Loans Payable $8.61M.
- 2025-12-31: Notes and Loans Payable $7.29M.
- 2025-09-30: Notes and Loans Payable $7.09M.
| Period end | Notes and Loans Payable |
|---|---|
| 2026-06-30 | $17.21M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $8.61M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.29M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $7.09M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $11.20M 10-Q · filed 2025-08-19 |
| 2025-03-31 | $6.00M 10-Q/A · filed 2025-08-19 |
| 2024-12-31 | $10.22M 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |